Skip to main content

Table 1 Characteristics of the study population

From: Unspecific post-mortem findings despite multiorgan viral spread in COVID-19 patients

ID Age Sex Comorbidities CT scan rRT-PCR Time to death Ante-mortem organ failure Treatments Cause of death
1 77 M CAD
CVD
Diabetes
NEG POS 3 ARDS
AKI
Mechanical ventilation
Antibiotics
Cardiogenic shock
MOF
2 91 F Hypertension
CAD
CRF
Liver cirrhosis
NEG POS 15 ARDS
AKI
Hypoxic hepatitis
Hydroxychloroquine
Antibiotics
Corticosteroids
Respiratory failure
3 68 M COPD
Cancer
GGO POS 15 ARDS
AKI
Mechanical ventilation
Hydroxychloroquine Lopinavir/Ritonavir
Antibiotics
Respiratory failure
4 64 F Hypertension
Cancer
CVD
MA POS 8 ARDS Mechanical ventilation
Hydroxychloroquine Antibiotics
Respiratory failure
5 56 M COPD
Cancer
GGO POS 14 ARDS
AKI
Hypoxic hepatitis
Mechanical ventilation ECMO
RRT
Hydroxychloroquine
Lopinavir/Ritonavir
Antibiotics
Mesenteric ischemia
MOF
6 73 M Hypertension
CRF
BC POS 11 ARDS
AKI
Mechanical ventilation ECMO
Hydroxychloroquine
Remdesivir
Corticosteroids
Antiobiotics
Respiratory failure
7 56 M None BC POS 7 ARDS
AKI
Hypoxic hepatitis
Hydroxychloroquine Antibiotics Respiratory failure
8 66 M Hypertension
CAD
CVD
CRF
Diabetes
Emphysema POS 14 AKI Antibiotics Septic shock
MOF
9 49 F Hypertension
Diabetes
GGO POS 17 ARDS
AKI
Mechanical ventilation RRT
Hydroxychloroquine
Lopinavir/Ritonavir
Antibiotics
Respiratory failure
10 63 M Hypertension
Diabetes
GGO
BC
POS 16 ARDS
AKI
Mechanical ventilation
ECMO
RRT
Hydroxychloroquine
Oseltamivir
Antibiotics
Respiratory failure
11 76 M Diabetes
Liver cirrhosis
Cancer
Diabetes
BC POS 5 ARDS Hydroxychloroquine
Antibiotics
Sudden death
12 75 M Hypertension
CAD
Diabetes
GGO POS 6 ARDS
AKI
Hypoxic hepatitis
Mechanical ventilation
Hydroxychloroquine
Antibiotics
MOF
13 73 M Diabetes GGO
BC
POS 10 ARDS Hydroxychloroquine Respiratory failure
14 77 F Hypertension
Diabetes
GGO
BC
POS 9 ARDS
AKI
Hypoxic hepatitis
Hydroxychloroquine
Antibiotics
Respiratory failure
15 61 M   GGO
LP
POS 31 ARDS
AKI
Pulmonary embolism
Mechanical ventilation
RRT
Hydroxychloroquine
Remdesivir
Antibiotics
Septic shock
MOF
16 70 F Hypertension
Diabetes
Liver transplant
GGOBC POS 19 ARDS
AKI
Pulmonary embolism
Mechanical ventilation
RRT
Hydroxychloroquine
Antibiotics
Septic shock
MOF
17 53 M Hypertension
CVD
GGO
BC
LP
POS 13 ARDS
AKI
Pulmonary embolism
Mechanical ventilation
ECMO
RRT
Hydroxychloroquine
Antibiotics
Septic shock
MOF
  1. Time to death time from admission to death (days). Cause of death was reported by the attending physician. M male, F female, rRT-PCR reverse transcription real-time polymerase chain reaction used as diagnostic laboratory test, NEG negative, POS positive, CAD coronary artery disease, CVD cerebrovascular disease, LP lobar pneumonia, GGO ground-glass opacity, MA minor abnormalities, BC bilateral consolidation, COPD chronic obstructive pulmonary disease, CRF chronic renal failure, ARDS acute respiratory distress syndrome, AKI acute kidney injury, ECMO extracorporeal membrane oxygenation, RRT renal replacement therapy, MOF multiple organ failure